| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRSL.2020.03.012 |
| P698 | PubMed publication ID | 32360945 |
| P2093 | author name string | Damani A Piggott | |
| Susan Tuddenham | |||
| P2860 | cites work | Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans | Q21133618 |
| The gut flora as a forgotten organ | Q24550824 | ||
| Human gut microbiome viewed across age and geography | Q24602950 | ||
| Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk | Q24603491 | ||
| Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
| Homeostasis and inflammation in the intestine | Q24613509 | ||
| Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa | Q24622141 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| Intestinal permeability defects: is it time to treat? | Q24629228 | ||
| Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
| Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment | Q24642137 | ||
| Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system | Q24680733 | ||
| The Gut Microbiota in Immune-Mediated Inflammatory Diseases | Q26741414 | ||
| Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection | Q26748743 | ||
| Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis | Q26781239 | ||
| Frailty: a tale of two concepts | Q26799116 | ||
| HIV, opiates, and enteric neuron dysfunction | Q27023420 | ||
| Has the microbiota played a critical role in the evolution of the adaptive immune system? | Q27098541 | ||
| The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy | Q91355593 | ||
| Altered Gut Microbiota and Host Metabolite Profiles in HIV-infected Women | Q91363025 | ||
| Effects of Probiotics and Prebiotics on Frailty and Ageing: A Narrative Review | Q91371782 | ||
| HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration | Q91628556 | ||
| The Unexplored World of Human Virome, Mycobiome, and Archaeome in Aging | Q91698936 | ||
| The Impact of the Microbiome on Immunosenescence | Q91700432 | ||
| Viruses and immunosenescence - more players in the game | Q91725154 | ||
| Relationship between oral and gut microbiota in elderly people | Q91874538 | ||
| Frailty transitions, inflammation and mortality among persons aging with HIV infection and injection drug use | Q91897701 | ||
| Polypharmacy in HIV: recent insights and future directions | Q91952346 | ||
| Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia | Q91994628 | ||
| Aging, sex, inflammation, frailty, and CMV and HIV infections | Q92018721 | ||
| Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation | Q92436580 | ||
| Exercise and the Gut Microbiome: A Review of the Evidence, Potential Mechanisms, and Implications for Human Health | Q92442444 | ||
| The Microbiome Mediates Environmental Effects on Aging | Q92486171 | ||
| The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging | Q92557741 | ||
| Gut microbiota and physical frailty through the mediation of sarcopenia | Q92938204 | ||
| Impact of Acute HIV Infection and Early Antiretroviral Therapy on the Human Gut Microbiome | Q104481548 | ||
| Alterations in the gut microbiota associated with HIV-1 infection | Q34986967 | ||
| SIV-induced instability of the chimpanzee gut microbiome | Q34986975 | ||
| Inflammatory markers in population studies of aging | Q34995451 | ||
| Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection | Q35030160 | ||
| Anal microbiota profiles in HIV-positive and HIV-negative MSM. | Q35066385 | ||
| Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection | Q35078598 | ||
| The bile acid membrane receptor TGR5: a valuable metabolic target | Q35082232 | ||
| Microbes, microbiota, and colon cancer | Q35120938 | ||
| Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, and inflammation | Q35125974 | ||
| Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial | Q35171253 | ||
| The cross talk between microbiota and the immune system: metabolites take center stage | Q35213604 | ||
| HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy | Q35216193 | ||
| Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. | Q35434347 | ||
| Gut microbiota are related to Parkinson's disease and clinical phenotype | Q35492461 | ||
| The microbiota and microbiome in aging: potential implications in health and age-related diseases | Q35528261 | ||
| Dysbiotic bacteria translocate in progressive SIV infection. | Q35542433 | ||
| Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection | Q35617066 | ||
| Enhanced immune activation linked to endotoxemia in HIV-1 seronegative MSM. | Q35701186 | ||
| The intestinal microbiome and health | Q35735284 | ||
| Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART. | Q35741375 | ||
| Short-chain fatty acids in control of body weight and insulin sensitivity | Q35741824 | ||
| Distinct Shifts in Microbiota Composition during Drosophila Aging Impair Intestinal Function and Drive Mortality | Q35760048 | ||
| Gut microbiota diversity predicts immune status in HIV-1 infection. | Q35768934 | ||
| Predicting a human gut microbiota's response to diet in gnotobiotic mice | Q35829905 | ||
| Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota | Q35860108 | ||
| Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection | Q35892944 | ||
| Gut microbiota and aging. | Q35898070 | ||
| Signatures of early frailty in the gut microbiota | Q35907894 | ||
| Bile acid metabolism and the pathogenesis of type 2 diabetes | Q35917864 | ||
| Future challenges for clinical care of an ageing population infected with HIV: a modelling study | Q35925654 | ||
| Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques | Q35943919 | ||
| Microbiome alterations in HIV infection a review | Q35946623 | ||
| Fecal bacterial microbiome diversity in chronic HIV-infected patients in China | Q35980520 | ||
| Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy | Q36068286 | ||
| Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients | Q40225216 | ||
| The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects | Q40400842 | ||
| Gut microbiota associated with HIV infection is significantly enriched in bacteria tolerant to oxygen | Q40567962 | ||
| Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy | Q40675523 | ||
| Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy | Q40735936 | ||
| The effect of heritability and host genetics on the gut microbiota and metabolic syndrome | Q40813460 | ||
| Fecal Transplantation for Clostridium Difficile-"All Stool May Not Be Created Equal". | Q40813899 | ||
| Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. | Q41194710 | ||
| Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients | Q41328388 | ||
| Aging and sarcopenia associate with specific interactions between gut microbes, serum biomarkers and host physiology in rats. | Q41434529 | ||
| Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome | Q42257409 | ||
| Research on the human virome: where are we and what is next. | Q42543729 | ||
| Fecal microbiota composition and frailty | Q42590341 | ||
| Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review | Q42699381 | ||
| The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition | Q43287025 | ||
| Utilizing gnotobiotic models to inform the role of the microbiome in vaccine response heterogeneity. | Q46254164 | ||
| Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans | Q46256011 | ||
| Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice | Q46256586 | ||
| The nursing home elder microbiome stability and associations with age, frailty, nutrition and physical location. | Q46261848 | ||
| A review of the relationship between the gut microbiota and amino acid metabolism. | Q46303633 | ||
| Biological Aging and the Human Gut Microbiota | Q46376615 | ||
| Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. | Q46496889 | ||
| Germ-Free Mice Model for Studying Host-Microbial Interactions | Q46552867 | ||
| Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. | Q46720733 | ||
| Gut Microbiota Contribute to Age-Related Changes in Skeletal Muscle Size, Composition, and Function: Biological Basis for a Gut-Muscle Axis | Q47180560 | ||
| The twilight of immunity: emerging concepts in aging of the immune system | Q47291933 | ||
| Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis? | Q47323507 | ||
| Composition of salivary microbiota in elderly subjects. | Q47561389 | ||
| Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. | Q47666819 | ||
| Altered gut microbiome composition in HIV infection: causes, effects and potential intervention | Q47768645 | ||
| HIV and aging: role of the microbiome | Q47787098 | ||
| Microbiome-health interactions in older people | Q48030065 | ||
| Alterations in the gut microbiota of patients with acquired immune deficiency syndrome. | Q48091579 | ||
| The microbiota-gut-brain axis in obesity | Q48138111 | ||
| Gut Microbiota and IGF-1. | Q48179882 | ||
| Inflammation Strikes Again: Frailty and HIV. | Q48260948 | ||
| Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? | Q49196046 | ||
| The Human Virome. | Q49344682 | ||
| The interaction between smoking, alcohol and the gut microbiome. | Q49362092 | ||
| Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics. | Q49565626 | ||
| Frailty status and altered dynamics of circulating energy metabolism hormones after oral glucose in older women. | Q51350146 | ||
| A Lachnospiraceae-dominated bacterial signature in the fecal microbiota of HIV-infected individuals from Colombia, South America. | Q52355341 | ||
| Frailty and the gut. | Q52599987 | ||
| Extensive impact of non-antibiotic drugs on human gut bacteria. | Q52647893 | ||
| Inflammation and frailty in older women. | Q53549699 | ||
| Inflammation biomarkers and near-term death in older men. | Q53581064 | ||
| Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction. | Q54224356 | ||
| Effects of HIV, ART and prebiotics on the active fraction of the gut microbiota. | Q54230364 | ||
| Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. | Q54292519 | ||
| Response of Gut Microbiota to Metabolite Changes Induced by Endurance Exercise. | Q55261900 | ||
| Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell count. | Q55442750 | ||
| Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty | Q56337838 | ||
| Long-Term Risks of Death and Institutionalization of Elderly People in Relation to Deficit Accumulation at Age 70 | Q56679969 | ||
| Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection | Q57185097 | ||
| From Bedside to Bench: Research Agenda for Frailty | Q57392338 | ||
| IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques | Q27320132 | ||
| Host Gut Motility Promotes Competitive Exclusion within a Model Intestinal Microbiota | Q27341819 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| Probiotics in Human Immunodeficiency Virus Infection: A Systematic Review and Evidence Synthesis of Benefits and Risks | Q28069649 | ||
| Inflammation and frailty in the elderly: A systematic review and meta-analysis | Q28072928 | ||
| Ageing Is Associated with Decreases in Appetite and Energy Intake--A Meta-Analysis in Healthy Adults | Q28074100 | ||
| The hallmarks of aging | Q28131641 | ||
| Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
| Frailty in older adults: evidence for a phenotype | Q28205094 | ||
| Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study | Q28213764 | ||
| A comparison of two approaches to measuring frailty in elderly people | Q28236735 | ||
| Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care | Q28251375 | ||
| The end of AIDS: HIV infection as a chronic disease | Q28300749 | ||
| Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics | Q28303404 | ||
| Phenotype of frailty: characterization in the women's health and aging studies | Q28304047 | ||
| Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity | Q28387426 | ||
| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
| Frailty, HIV infection, and mortality in an aging cohort of injection drug users | Q28485898 | ||
| NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion | Q28512429 | ||
| Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Q28512778 | ||
| Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada | Q28537704 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans | Q29614455 | ||
| The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice | Q29614457 | ||
| Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
| The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis | Q29616351 | ||
| Richness of human gut microbiome correlates with metabolic markers | Q29617365 | ||
| Gut microbiota composition correlates with diet and health in the elderly | Q29617441 | ||
| Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach | Q29617547 | ||
| Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation | Q29617796 | ||
| Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation | Q29620116 | ||
| Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions | Q30244921 | ||
| Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs | Q30248351 | ||
| Cytomegalovirus infection enhances the immune response to influenza. | Q30300254 | ||
| Composition, variability, and temporal stability of the intestinal microbiota of the elderly | Q30499047 | ||
| The estimation of relative fitness and frailty in community-dwelling older adults using self-report data | Q30939935 | ||
| Incorporating microbiota data into epidemiologic models: examples from vaginal microbiota research. | Q31088120 | ||
| The microbiome and innate immunity | Q36069070 | ||
| Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial. | Q36096116 | ||
| Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials | Q36096223 | ||
| Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression | Q36132003 | ||
| Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease | Q36212145 | ||
| Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice | Q36228463 | ||
| Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV. | Q36275850 | ||
| Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use. | Q36276469 | ||
| Differences in gut microbiota profile between women with active lifestyle and sedentary women. | Q36277135 | ||
| Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial | Q36339858 | ||
| Microbial metabolites in health and disease: Navigating the unknown in search of function | Q36340571 | ||
| The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging | Q36410021 | ||
| Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis | Q36452414 | ||
| Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults | Q36507668 | ||
| Interleukin-6 in aging and chronic disease: a magnificent pathway | Q36518670 | ||
| Xenobiotics shape the physiology and gene expression of the active human gut microbiome | Q36554412 | ||
| Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected Macaques | Q36664297 | ||
| Gut immune dysfunction through impaired innate pattern recognition receptor expression and gut microbiota dysbiosis in chronic SIV infection | Q36693342 | ||
| Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments. | Q36726253 | ||
| Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells | Q36880342 | ||
| Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? | Q36901589 | ||
| Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial. | Q37050763 | ||
| Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population. | Q37141323 | ||
| Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions | Q37157802 | ||
| The long-term stability of the human gut microbiota | Q37217949 | ||
| Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection | Q37317771 | ||
| Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine | Q37345533 | ||
| Total and cause-specific mortality in the cardiovascular health study | Q37413113 | ||
| Functional metagenomic profiling of intestinal microbiome in extreme ageing | Q37445053 | ||
| Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults | Q37470727 | ||
| Enteric defensins are essential regulators of intestinal microbial ecology | Q37483232 | ||
| Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. | Q37589158 | ||
| A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects | Q37595511 | ||
| Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors | Q57652772 | ||
| The Oral Microbiota Is Modified by Systemic Diseases | Q57787288 | ||
| A gut microbial factor modulates locomotor behaviour in Drosophila | Q57793637 | ||
| Interplay between gut microbiota metabolism and inflammation in HIV infection | Q58038972 | ||
| Repeated rectal application of a hyperosmolar lubricant is associated with microbiota shifts but does not affect PrEP drug concentrations: results from a randomized trial in men who have sex with men | Q58125505 | ||
| An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men | Q58611298 | ||
| Enrichment of gut-derived Fusobacterium is associated with suboptimal immune recovery in HIV-infected individuals | Q58700642 | ||
| Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection | Q59353468 | ||
| Insulin Resistance and Inflammation as Precursors of Frailty | Q59442589 | ||
| An Investigation Into Physical Frailty as a Link Between the Gut Microbiome and Cognitive Health | Q60046797 | ||
| Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020 | Q60049153 | ||
| Endocrine and inflammatory markers as predictors of frailty | Q60298081 | ||
| Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study | Q61663307 | ||
| Socioeconomic Status and the Gut Microbiome: A TwinsUK Cohort Study | Q61796613 | ||
| Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity | Q61799636 | ||
| Age-dependent changes in GI physiology and microbiota: time to reconsider? | Q63379432 | ||
| Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption | Q63816416 | ||
| Evolution of the gut microbiome following acute HIV-1 infection | Q64057691 | ||
| Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infection | Q64078044 | ||
| Altered Immunity and Microbial Dysbiosis in Aged Individuals With Long-Term Controlled HIV Infection | Q64102276 | ||
| Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial | Q64103068 | ||
| Among older adults, age-related changes in the stool microbiome differ by HIV-1 serostatus | Q64261290 | ||
| Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism | Q64786944 | ||
| Aerobic Exercise Training with Brisk Walking Increases Intestinal Bacteroides in Healthy Elderly Women. | Q64912046 | ||
| Aging-associated increase in intestinal permeability to polyethylene glycol 900 | Q69748579 | ||
| Accumulation of deficits as a proxy measure of aging | Q73523060 | ||
| Small bowel enterocyte apoptosis and proliferation are increased in the elderly | Q74254435 | ||
| Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study | Q74497792 | ||
| Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly | Q77769291 | ||
| Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women | Q81722105 | ||
| Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly | Q83680262 | ||
| HIV and aging--preparing for the challenges ahead | Q83809513 | ||
| The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages | Q88277726 | ||
| Smoking and the intestinal microbiome | Q88295563 | ||
| Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus | Q88773848 | ||
| Composition and richness of the serum microbiome differ by age and link to systemic inflammation | Q88993170 | ||
| Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries | Q89747167 | ||
| Regional Diversity of the Gastrointestinal Microbiome | Q90077272 | ||
| The Gut Microbiota and Healthy Aging: A Mini-Review | Q90343911 | ||
| Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection | Q90601603 | ||
| Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Disease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus | Q90779138 | ||
| Frailty as a predictor of falls in HIV-infected and uninfected women | Q90860886 | ||
| Effects of HIV viremia on the gastrointestinal microbiome of young MSM | Q91070892 | ||
| The impact of in utero HIV exposure on gut microbiota, inflammation, and microbial translocation | Q91106545 | ||
| Frailty predicts fractures among women with and at-risk for HIV | Q91288927 | ||
| Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population | Q37636104 | ||
| HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota | Q37677371 | ||
| Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens | Q37682227 | ||
| HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage | Q37699887 | ||
| Probiotic bacteria and intestinal epithelial barrier function | Q37714234 | ||
| Long-term impacts of antibiotic exposure on the human intestinal microbiota | Q37779673 | ||
| Impact of probiotics on colonizing microbiota of the gut. | Q37944976 | ||
| Intestinal microbiota is a plastic factor responding to environmental changes | Q38016621 | ||
| Bacteria as vitamin suppliers to their host: a gut microbiota perspective | Q38039782 | ||
| NOD proteins: regulators of inflammation in health and disease | Q38171221 | ||
| The SCFA Receptor GPR43 and Energy Metabolism | Q38219970 | ||
| Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients | Q38363782 | ||
| Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis | Q38596060 | ||
| Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals. | Q38765317 | ||
| Mechanisms of Pediatric Inflammatory Bowel Disease | Q38832080 | ||
| Reduced Intestinal Motility, Mucosal Barrier Function, and Inflammation in Aged Monkeys | Q38873846 | ||
| Association between myocyte quality control signaling and sarcopenia in old hip-fractured patients: Results from the Sarcopenia in HIp FracTure (SHIFT) exploratory study. | Q38883219 | ||
| Probiotics, gut microbiota, and their influence on host health and disease. | Q38921638 | ||
| Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation | Q38973447 | ||
| Signals from the gut microbiota to distant organs in physiology and disease | Q38973619 | ||
| Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria. | Q39001817 | ||
| The Oral Microbiome in Health and Its Implication in Oral and Systemic Diseases. | Q39031552 | ||
| Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review | Q39179063 | ||
| The genetics of human longevity: an intricacy of genes, environment, culture and microbiome | Q39228896 | ||
| Implications of the gut microbiota in vulnerability to the social avoidance effects of chronic social defeat in male mice | Q39308508 | ||
| Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System | Q39381331 | ||
| Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subset-specific manner | Q39432258 | ||
| Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21. | Q39653631 | ||
| HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases | Q39758513 | ||
| Gut Microbiota and Extreme Longevity | Q39761648 | ||
| Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults: a prospective cohort study | Q40083923 | ||
| Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages. | Q40093280 | ||
| Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers | Q40121502 | ||
| An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. | Q31147419 | ||
| The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. | Q33464704 | ||
| Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble | Q33551550 | ||
| Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation | Q33553358 | ||
| Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction. | Q33567407 | ||
| Systemic effects of inflammation on health during chronic HIV infection | Q33577551 | ||
| Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians | Q33586253 | ||
| Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care | Q33668524 | ||
| Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections | Q33680743 | ||
| The rectal mucosa and condomless receptive anal intercourse in HIV-negative MSM: implications for HIV transmission and prevention | Q33694217 | ||
| HIV/AIDS, undernutrition, and food insecurity | Q33701378 | ||
| Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients | Q33787675 | ||
| Microbiota and Probiotics in Health and HIV Infection. | Q33852108 | ||
| Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism | Q33889154 | ||
| Frailty in elderly people | Q33902569 | ||
| Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection | Q33936619 | ||
| Microbes in gastrointestinal health and disease | Q33943525 | ||
| Comparison of the gut microbiotas of healthy adult twins living in South Korea and the United States | Q34004511 | ||
| The inflammatory status of old age can be nurtured from the intestinal environment | Q34008865 | ||
| Dietary intervention impact on gut microbial gene richness | Q34037982 | ||
| HIV infection, inflammation, immunosenescence, and aging | Q34150710 | ||
| Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis | Q34187114 | ||
| Probiotics for prevention and treatment of diarrhea. | Q34223539 | ||
| Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome | Q34305895 | ||
| Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. | Q34308383 | ||
| Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection | Q34315572 | ||
| Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment | Q34315579 | ||
| Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial | Q34451794 | ||
| Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome | Q34517656 | ||
| Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. | Q34518423 | ||
| The frailty syndrome: definition and natural history | Q34528315 | ||
| The microbiota in adaptive immune homeostasis and disease | Q34533142 | ||
| Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease | Q34555620 | ||
| Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner | Q34562535 | ||
| Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation | Q34574485 | ||
| Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective | Q34629039 | ||
| Human genetics shape the gut microbiome. | Q34630305 | ||
| The biology of aging and frailty | Q34644417 | ||
| Human gut microbiota community structures in urban and rural populations in Russia | Q34656085 | ||
| Gut Microbiota Linked to Sexual Preference and HIV Infection. | Q34676893 | ||
| Microbiota organization is a distinct feature of proximal colorectal cancers | Q34793322 | ||
| Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey | Q34969764 | ||
| P577 | publication date | 2020-04-30 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | The Gut Microbiome and Frailty |
| Q98209208 | GUT DYSBIOSIS AND AGE-RELATED NEUROLOGICAL DISEASES; AN INNOVATIVE APPROACH FOR THERAPEUTIC INTERVENTIONS | cites work | P2860 |
Search more.